[ad_1] RT @OphthalmicPro: Gene therapy has gotten some major buzz in the medical community of late. In this issue, Dr. Thomas Ciulla gives us a pr… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] Vascular alterations in macular degeneration and diabetic retinopathy, reviewed in this chapter we just published…. https://t.co/X0OzpZAMga [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
RT @RetinalPhys: NEW PRODUCT APPLICATIONS: Data Analytics Give Retinal Physicians an Edge: Designed for these users, analytics provide insi…
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] Just co-authored this paper…Despite new therapies for AMD, the leading causing of vision loss, treatment burden and limited outcomes persist… https://t.co/onrebZdz0q https://t.co/oXoIsnL6rk [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] Recently published this chapter on Vitreous Pathology, which contributes to vitreomacular traction, macular hole & pucker, retinal detachment, & macular edema. Vitreous has a role in proliferative diabetic retinopathy.. https://t.co/mkfqrPCoHl [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
Just published this chapter on the physiology of the vitreous, one of nature’s important drug delivery systems….
https://t.co/JWH5uh1zUI
[ad_2]
Source by Thomas Ciulla, MD, MBA
Recently contributed to this article on data analytics, which provide insights for benchmarking, clinical trials and research…. https://www.retinalphysician.com/issues/2019/november-2019/new-product-applications-data-analytics-give-retin Return to main website.
Great interest in process improvement with a well attended course https://www.retinalphysician.com/issues/2018/january-2018/lean-six-sigma-process-improvement-in-the-retina-c Return to main website.
Just co-authored, “Tie-2/Angiopoietin pathway modulation as a therapeutic strategy for retinal disease”…
https://www.tandfonline.com/eprint/W6NWBTIVBFBQDYE8MTPH/full?target=10.1080/13543784.2019.1667333
Recently presented real world anti-VEGF outcomes in 28,456 eyes with Diabetic Macular Edema, showing large unmet need… Return to main website.